Fresenius sold 13.4 million shares in Fresenius Medical Care at EUR39.00 per share, reducing its stake to about 20% and generating gross proceeds of approximately EUR524 million. The proceeds will fund growth platforms under the FutureFresenius strategy. A book gain in the low-to-mid double-digit million euro range will be recorded in Q4 2026. Fresenius shares rose 2% on the news.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.
